Implication of gut microbiota metabolites in cardiovascular and metabolic diseases

[1]  C. Pepine,et al.  Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. , 2018, Clinical science.

[2]  J. Sanderson,et al.  Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota , 2018, bioRxiv.

[3]  Aleksandra A. Kolodziejczyk,et al.  Bile acids in glucose metabolism in health and disease , 2018, The Journal of experimental medicine.

[4]  A. Molinaro,et al.  Role of Bile Acids in Metabolic Control , 2018, Trends in Endocrinology & Metabolism.

[5]  A. Goto,et al.  Association between plasma concentrations of branched-chain amino acids and adipokines in Japanese adults without diabetes , 2018, Scientific Reports.

[6]  Lin Shi,et al.  Plasma metabolites associated with type 2 diabetes in a Swedish population: a case–control study nested in a prospective cohort , 2018, Diabetologia.

[7]  S. Hazen,et al.  Microbial modulation of cardiovascular disease , 2018, Nature Reviews Microbiology.

[8]  C. Stanton,et al.  Bile acids at the cross-roads of gut microbiome–host cardiometabolic interactions , 2017, Diabetology & Metabolic Syndrome.

[9]  S. A. Arriola Apelo,et al.  Restoration of metabolic health by decreased consumption of branched‐chain amino acids , 2017, The Journal of physiology.

[10]  J. Blanchard,et al.  Bacterial Branched-Chain Amino Acid Biosynthesis: Structures, Mechanisms, and Drugability. , 2017, Biochemistry.

[11]  T. Spector,et al.  Hippurate as a metabolomic marker of gut microbiome diversity: Modulation by diet and relationship to metabolic syndrome , 2017, Scientific Reports.

[12]  Arthur Brady,et al.  Strains, functions and dynamics in the expanded Human Microbiome Project , 2017, Nature.

[13]  F. Rey,et al.  Metabolic, Epigenetic, and Transgenerational Effects of Gut Bacterial Choline Consumption. , 2017, Cell host & microbe.

[14]  N. Abumrad,et al.  Bile acids and bariatric surgery. , 2017, Molecular aspects of medicine.

[15]  Quan Gu,et al.  Microbial-Host Co-metabolites Are Prodromal Markers Predicting Phenotypic Heterogeneity in Behavior, Obesity, and Impaired Glucose Tolerance , 2017, Cell reports.

[16]  Richard G. Lee,et al.  The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue. , 2017, Cell reports.

[17]  J. Holst,et al.  Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men: a randomized crossover trial , 2017, Scientific Reports.

[18]  P. Langella,et al.  Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria , 2017, Microbial Cell Factories.

[19]  B. Staels,et al.  Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia and NAFLD. , 2017 .

[20]  Jussi Paananen,et al.  Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study , 2017, Scientific Reports.

[21]  A. El-Osta,et al.  High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice , 2017, Circulation.

[22]  H. Berthoud,et al.  Gut-Brain Cross-Talk in Metabolic Control , 2017, Cell.

[23]  T. Hansen,et al.  Genetic evidence of a causal effect of insulin resistance on branched-chain amino acid levels , 2017, Diabetologia.

[24]  E. Chambers,et al.  The diet‐derived short chain fatty acid propionate improves beta‐cell function in humans and stimulates insulin secretion from human islets in vitro , 2017, Diabetes, obesity & metabolism.

[25]  C. Cho,et al.  Trimethylamine-N-Oxide: Friend, Foe, or Simply Caught in the Cross-Fire? , 2017, Trends in Endocrinology & Metabolism.

[26]  M. Vaneechoutte,et al.  p-Cresyl Sulfate , 2017, Toxins.

[27]  Di Zhang,et al.  Metabolic regulation of gene expression through histone acylations , 2016, Nature Reviews Molecular Cell Biology.

[28]  T. Spector,et al.  Associations between branched chain amino acid intake and biomarkers of adiposity and cardiometabolic health independent of genetic factors: A twin study☆ , 2016, International journal of cardiology.

[29]  Inês Barroso,et al.  Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis , 2016, PLoS medicine.

[30]  M. Ferruzzi,et al.  Altered Transport and Metabolism of Phenolic Compounds in Obesity and Diabetes: Implications for Functional Food Development and Assessment. , 2016, Advances in nutrition.

[31]  D. Raj,et al.  Trimethylamine N-Oxide: The Good, the Bad and the Unknown , 2016, Toxins.

[32]  S. Flavahan,et al.  Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41. , 2016, Physiological genomics.

[33]  P. Bork,et al.  Human gut microbes impact host serum metabolome and insulin sensitivity , 2016, Nature.

[34]  S. A. Arriola Apelo,et al.  Decreased Consumption of Branched-Chain Amino Acids Improves Metabolic Health. , 2016, Cell reports.

[35]  F. Bäckhed,et al.  Microbiota-Produced Succinate Improves Glucose Homeostasis via Intestinal Gluconeogenesis. , 2016, Cell metabolism.

[36]  E. Zoetendal,et al.  Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial. , 2016, Cell metabolism.

[37]  F. Bäckhed,et al.  Diet–microbiota interactions as moderators of human metabolism , 2016, Nature.

[38]  J. Borén,et al.  Metabolic transformations of dietary polyphenols: comparison between in vitro colonic and hepatic models and in vivo urinary metabolites. , 2016, The Journal of nutritional biochemistry.

[39]  F. Bäckhed,et al.  From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites , 2016, Cell.

[40]  F. Schick,et al.  Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans , 2016, Scientific Reports.

[41]  K. Petersen,et al.  Acetate mediates a microbiome-brain-β cell axis promoting metabolic syndrome , 2016, Nature.

[42]  R. Roeder,et al.  Dynamic Competing Histone H4 K5K8 Acetylation and Butyrylation Are Hallmarks of Highly Active Gene Promoters , 2016, Molecular cell.

[43]  A. Sulpizio,et al.  L‐carnitine intake and high trimethylamine N‐oxide plasma levels correlate with low aortic lesions in ApoE−/− transgenic mice expressing hCETP , 2016, Atherosclerosis.

[44]  S. Hazen,et al.  Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk , 2016, Cell.

[45]  J. Segre,et al.  Signaling in Host-Associated Microbial Communities , 2016, Cell.

[46]  Y. Bao,et al.  Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry. , 2016, Journal of proteome research.

[47]  S. Haffner,et al.  Branched-Chain Amino Acids and Insulin Metabolism: The Insulin Resistance Atherosclerosis Study (IRAS) , 2016, Diabetes Care.

[48]  Jun Wang,et al.  Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota , 2015, Nature.

[49]  Wen-Chang Chang,et al.  Protective Effect of Vanillic Acid against Hyperinsulinemia, Hyperglycemia and Hyperlipidemia via Alleviating Hepatic Insulin Resistance and Inflammation in High-Fat Diet (HFD)-Fed Rats , 2015, Nutrients.

[50]  A. von Eckardstein,et al.  Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control. , 2015, Atherosclerosis.

[51]  Ellen E. Blaak,et al.  Short-chain fatty acids in control of body weight and insulin sensitivity , 2015, Nature Reviews Endocrinology.

[52]  Fredrik H. Karlsson,et al.  Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation , 2015, Cell metabolism.

[53]  Gabi Kastenmüller,et al.  A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control , 2015, Diabetologia.

[54]  Jianping Ye,et al.  Sodium butyrate epigenetically modulates high‐fat diet‐induced skeletal muscle mitochondrial adaptation, obesity and insulin resistance through nucleosome positioning , 2015, British journal of pharmacology.

[55]  M. Trauner,et al.  Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity , 2015, Journal of hepatology.

[56]  P. Elliott,et al.  Urinary metabolic signatures of human adiposity , 2015, Science Translational Medicine.

[57]  B. Neuschwander‐Tetri,et al.  Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial , 2015, The Lancet.

[58]  D. Gauguier,et al.  Plaque burden in HIV-infected patients is associated with serum intestinal microbiota-generated trimethylamine , 2015, AIDS.

[59]  Omry Koren,et al.  Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome , 2015, Nature.

[60]  Jimmy D Bell,et al.  Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults , 2014, Gut.

[61]  N. Buys,et al.  Effect of Probiotics on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials , 2014, Hypertension.

[62]  E. Segal,et al.  Artificial sweeteners induce glucose intolerance by altering the gut microbiota , 2014, Nature.

[63]  N. Shimba,et al.  Plasma amino acid profiles are associated with insulin, C-peptide and adiponectin levels in type 2 diabetic patients , 2014, Nutrition & Diabetes.

[64]  G. Frost,et al.  The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents , 2014, International Journal of Obesity.

[65]  S. Yano,et al.  Effects of uremic toxin p-cresol on proliferation, apoptosis, differentiation, and glucose uptake in 3T3-L1 cells. , 2014, Artificial organs.

[66]  A. Rowland,et al.  Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins , 2014, European Journal of Clinical Pharmacology.

[67]  E. Zoetendal,et al.  Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. , 2014, Journal of hepatology.

[68]  V. Tremaroli,et al.  FXR is a molecular target for the effects of vertical sleeve gastrectomy , 2014, Nature.

[69]  F. Bäckhed,et al.  Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits , 2014, Cell.

[70]  Christian Gieger,et al.  Biomarkers for Type 2 Diabetes and Impaired Fasting Glucose Using a Nontargeted Metabolomics Approach , 2013, Diabetes.

[71]  S. Parkar,et al.  Fecal microbial metabolism of polyphenols and its effects on human gut microbiota. , 2013, Anaerobe.

[72]  J. Clemente,et al.  Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice , 2013, Science.

[73]  S. Mudaliar,et al.  Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. , 2013, Gastroenterology.

[74]  P. Bork,et al.  Richness of human gut microbiome correlates with metabolic markers , 2013, Nature.

[75]  B. Aronow,et al.  Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight-loss-independent manner , 2013, Obesity.

[76]  G. Tsujimoto,et al.  The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43 , 2013, Nature Communications.

[77]  S. Hazen,et al.  Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. , 2013, The New England journal of medicine.

[78]  F. Bushman,et al.  Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis , 2013, Nature Medicine.

[79]  I. Wilson,et al.  Hippurate: the natural history of a mammalian-microbial cometabolite. , 2013, Journal of proteome research.

[80]  H. Flint,et al.  Major phenylpropanoid-derived metabolites in the human gut can arise from microbial fermentation of protein. , 2013, Molecular nutrition & food research.

[81]  J. Gordon,et al.  Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation , 2013, Proceedings of the National Academy of Sciences.

[82]  T. Hummel,et al.  Human Trace Amine-Associated Receptor TAAR5 Can Be Activated by Trimethylamine , 2013, PloS one.

[83]  Kevin D Young,et al.  Indole production by the tryptophanase TnaA in Escherichia coli is determined by the amount of exogenous tryptophan. , 2013, Microbiology.

[84]  Brian J. Bennett,et al.  Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. , 2013, Cell metabolism.

[85]  E. Edelman,et al.  Uremic Serum and Solutes Increase Post–Vascular Interventional Thrombotic Risk Through Altered Stability of Smooth Muscle Cell Tissue Factor , 2012, Circulation.

[86]  Qiang Feng,et al.  A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.

[87]  M. Blaser,et al.  Antibiotics in early life alter the murine colonic microbiome and adiposity , 2012, Nature.

[88]  J. Nicholson,et al.  Host-Gut Microbiota Metabolic Interactions , 2012, Science.

[89]  J. Nicholson,et al.  Genetic determinants of metabolism in health and disease: from biochemical genetics to genome-wide associations , 2012, Genome Medicine.

[90]  Hua V. Lin,et al.  Butyrate and Propionate Protect against Diet-Induced Obesity and Regulate Gut Hormones via Free Fatty Acid Receptor 3-Independent Mechanisms , 2012, PloS one.

[91]  L. Calani,et al.  Identification of microbial metabolites derived from in vitro fecal fermentation of different polyphenolic food sources. , 2012, Nutrition.

[92]  Wei Sun,et al.  The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. , 2011, Cell metabolism.

[93]  V. Mootha,et al.  Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.

[94]  Brian J. Bennett,et al.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.

[95]  Oliver Fiehn,et al.  Plasma Metabolomic Profiles Reflective of Glucose Homeostasis in Non-Diabetic and Type 2 Diabetic Obese African-American Women , 2010, PloS one.

[96]  Christian Gieger,et al.  Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting , 2010, PloS one.

[97]  E. Want,et al.  Global metabolic profiling procedures for urine using UPLC–MS , 2010, Nature Protocols.

[98]  G. Mingrone,et al.  Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype , 2010, International Journal of Obesity.

[99]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[100]  E. Tai,et al.  Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men , 2010, Diabetologia.

[101]  A. Schwiertz,et al.  Microbiota and SCFA in Lean and Overweight Healthy Subjects , 2010, Obesity.

[102]  M. Miyata,et al.  Administration of Ampicillin Elevates Hepatic Primary Bile Acid Synthesis through Suppression of Ileal Fibroblast Growth Factor 15 Expression , 2009, Journal of Pharmacology and Experimental Therapeutics.

[103]  M. Blaser,et al.  What are the consequences of the disappearing human microbiota? , 2009, Nature Reviews Microbiology.

[104]  Z. Massy,et al.  Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[105]  John C Lindon,et al.  Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism , 2009, Proceedings of the National Academy of Sciences.

[106]  W. Cefalu,et al.  Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice , 2009, Diabetes.

[107]  Svati H Shah,et al.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.

[108]  G. Cresci,et al.  GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. , 2009, Cancer research.

[109]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[110]  Ian D. Wilson,et al.  Metabolic Phenotyping in Health and Disease , 2008, Cell.

[111]  Ian J. Brown,et al.  Human metabolic phenotype diversity and its association with diet and blood pressure , 2008, Nature.

[112]  T. Ebbels,et al.  Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts , 2007, Nature Protocols.

[113]  T. Hashimoto,et al.  1H NMR-based metabonomic analysis of urine from young spontaneously hypertensive rats. , 2007, Journal of pharmaceutical and biomedical analysis.

[114]  H. Yamashita,et al.  Improvement of Obesity and Glucose Tolerance by Acetate in Type 2 Diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) Rats , 2007, Bioscience, biotechnology, and biochemistry.

[115]  Dominique Gauguier,et al.  Direct quantitative trait locus mapping of mammalian metabolic phenotypes in diabetic and normoglycemic rat models , 2007, Nature Genetics.

[116]  R. Cox,et al.  A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. , 2007, Physiological genomics.

[117]  M. McCarthy,et al.  Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice , 2006, Proceedings of the National Academy of Sciences.

[118]  T. Mendoza,et al.  Changes in Gene Expression Foreshadow Diet-Induced Obesity in Genetically Identical Mice , 2006, PLoS Genetics.

[119]  J. Lindon,et al.  Pharmaco-metabonomic phenotyping and personalized drug treatment , 2006, Nature.

[120]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[121]  I. Wilson,et al.  Gut microorganisms, mammalian metabolism and personalized health care , 2005, Nature Reviews Microbiology.

[122]  P. Whelton,et al.  Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials , 2005, Journal of hypertension.

[123]  Ting Wang,et al.  The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[124]  S. Dowell,et al.  The Orphan G Protein-coupled Receptors GPR41 and GPR43 Are Activated by Propionate and Other Short Chain Carboxylic Acids* , 2003, The Journal of Biological Chemistry.

[125]  Bernard Thorens,et al.  Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. , 2002, American journal of physiology. Endocrinology and metabolism.

[126]  J. Lindon,et al.  Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.

[127]  D. Jenden,et al.  Choline deficiency: A cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation , 1995, Hepatology.

[128]  C. Nutting,et al.  Vasorelaxant effects of short chain fatty acid salts in rat caudal artery. , 1991, The American journal of physiology.

[129]  M. Mulvany,et al.  Short chain fatty acids dilate isolated human colonic resistance arteries. , 1990, Gut.

[130]  P. Felig,et al.  Plasma amino acid levels and insulin secretion in obesity. , 1969, The New England journal of medicine.

[131]  B. Wostmann,et al.  Fecal neutral steroids and bile acids from germfree rats. , 1969, Journal of lipid research.

[132]  S. Fajans,et al.  Stimulation of insulin secretion by amino acids. , 1966, The Journal of clinical investigation.

[133]  E. Edelman,et al.  The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia. , 2016, Journal of the American Society of Nephrology : JASN.

[134]  Nigel F. Delaney,et al.  Effects of sodium benzoate, a widely used food preservative, on glucose homeostasis and metabolic profiles in humans. , 2015, Molecular genetics and metabolism.

[135]  Jens Roat Kultima,et al.  Disentangling the effects of type 2 diabetes and metformin on the human gut microbiota , 2015, Nature.